C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2002
12/03/2002	US6489124 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. modulated by certain modulatory proteins. dna coding for a family of such modulatory proteins has now been isolated
12/03/2002	US6489104 Screening for a dna encoding a protein that regulates the human p27.sup.kip1 promoter activity of a promoter dna, said promoter dna comprising at least a substantial portion of a fragment extending from nucleotide 2795 to nucleotide 3133 of
12/03/2002	US6489099 Detection of DNA damaging agents
12/03/2002	US6489092 Method for sex determination of mammalian offspring
12/03/2002	US6488935 Dna coding for a peptide of a papilloma virus major capsid protein and a papilloma virus genome, respectively
12/03/2002	US6488930 Antibody or functional fragment thereof which binds to a mammalian (e.g., human) cc-chemokine receptor 4 (ccr4)
12/03/2002	US6488927 Fibrinolytic or anticoagulant drugs are biocompatibly coupled to red blood cell carriers.
12/03/2002	CA2284077C Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2060544C Recombinant antibodies specific for a growth factor receptor
12/03/2002	CA2050910C Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
11/2002
11/30/2002	CA2384352A1 Novel polynucleotides from streptomyces avermitilis
11/29/2002	WO2001092476A2 In vitro tissue test system
11/29/2002	CA2410946A1 In vitro tissue test system
11/28/2002	WO2002095497A2 Method of lift-off microstructuring deposition material on a substrate, substrates obtainable by the method, and use thereof
11/28/2002	WO2002095306A1 Cryopreservation system with controlled dendritic freezing front velocity
11/28/2002	WO2002095068A2 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095058A2 Emission ratiometric indicators of phosphorylation
11/28/2002	WO2002095055A2 Compositions and methods for use in isolation of nucleic acid molecules
11/28/2002	WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules
11/28/2002	WO2002095038A2 Vectors for enhanced expression of vegf for disease treatment
11/28/2002	WO2002095036A2 A novel intein and uses thereof
11/28/2002	WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002	WO2002095030A2 Modulation of cd200 receptors
11/28/2002	WO2002095029A2 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria
11/28/2002	WO2002095026A1 Method of proliferating terminal differentiated cells and recombinant vector therefor
11/28/2002	WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	WO2002095014A2 Polypeptides having cellobiase activity and polynucleotides encoding same
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095006A2 Muscle-specific expression vectors
11/28/2002	WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them
11/28/2002	WO2002095002A2 N4 virion single-stranded dna dependent rna polymerase
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094994A2 Chimeric antigen-specific t cell-activating polypeptides
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094987A2 In vitro production of haploid germ cells
11/28/2002	WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002	WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	WO2002094874A2 Internalisation of virus into cells
11/28/2002	WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002	WO2002094853A2 Antibodies specific for poly(ethylene glycol)
11/28/2002	WO2002094842A2 Control of myogenesis by modulation of p38 map kinase activity
11/28/2002	WO2002094780A2 Kinases and phosphatases
11/28/2002	WO2002094313A2 Vaccine composition
11/28/2002	WO2002094198A2 Modulation of cell division by an early mitotic inhibitor protein
11/28/2002	WO2002094196A2 Method of treatment for cancers associated with elevated
11/28/2002	WO2002094005A2 The use of drupes as a soil amendment to control nematodes
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002074345A3 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002066636A3 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/28/2002	WO2002066619A9 Methods of treating inflammation, particularly diabetes
11/28/2002	WO2002066599A3 Efficient method for the development of transgenic plants by gene manipulation
11/28/2002	WO2002062969A3 Cellular reprogramming in peptide hydrogel and uses thereof
11/28/2002	WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002	WO2002054065A3 Reversible mhc multimer staining for functional purification of antigen-specific t cells
11/28/2002	WO2002050310A9 Rolling circle amplification detection of rna and dna
11/28/2002	WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002	WO2002033052A3 Method for producing vital, biological substitute tissue in vitro using cell cultures and a support
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001098509A3 Grain processing method and transgenic plants useful therein
11/28/2002	WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002	WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002	WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178462 Prenatal screening
11/28/2002	US20020178461 Transgenic fish with tissue-specific expression
11/28/2002	US20020178460 Animal model for use as tools in genetic engineering
11/28/2002	US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002	US20020178457 Transgenic animals; genetic engineering
11/28/2002	US20020178456 Polyclonal antibodies for use inthe treatment and prevention of bacteria, fungi, virus and parasites infections
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177858 Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation
11/28/2002	US20020177668 Crosslinked acrylated unsaturated polyester yields degradation products non-toxic, metabolized and excreted by the human kidney; mechanical properties, i.e. compressive strength and modulus; low water absorption; grafting implants
11/28/2002	US20020177565 Toso proteins and related molecules which have an inhibitory effect on TNF mediated apoptosis
11/28/2002	US20020177553 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020177550 Administering to the subject a therapeutically effective amount of a form of soluble Receptor for Advanced Glycation Endproducts (RAGE).
11/28/2002	US20020177549 Which regulate cellular guidance and physiology, and related nucleic acids.
11/28/2002	US20020177544 Adenoviral transfer vector for the gene transport of a dna sequence
11/28/2002	US20020177230 Generating genetically engineered viral genome; obtain clones, incubate with restriction enzymes, recover nucleotide sequence, ligate and generate viral genome
11/28/2002	US20020177228 Method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
11/28/2002	US20020177227 Modulating cell differentiation of cultured stem cell; obtain cell, incubate with modulator, monitor adjustment in insulin-like growth factor activity, evaluate stem cell differentiation
11/28/2002	US20020177224 Tissue engineering enhanced by the transfer of a growth factor gene
11/28/2002	US20020177222 Replication competent AAV helper functions
11/28/2002	US20020177216 Culturing preferential mammalian virus; obtain mammalian cells, infect cell with virus, culture cells and recover viral particles
11/28/2002	US20020177215 Methods for producing purified adenoviral vectors
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020177210 Polypeptide for use as tools in food processing and genetic engineering
11/28/2002	US20020177203 Alpha2 subunit of prolyl 4-hydroxylase

1 ... 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 ... 1827